JTC-801
| SMILES | CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C |
| InChIKey | VTGBZWHPJFMTKS-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 411.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| NOP | OPRX | Human | Opioid | A | pKi | 8.1 | 8.1 | 8.1 | Guide to Pharmacology |
| 5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 5.56 | 5.56 | 5.56 | ChEMBL |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 5.45 | 5.45 | 5.45 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 5.68 | 5.68 | 5.68 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 5.5 | 5.5 | 5.5 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 5.2 | 5.2 | 5.2 | ChEMBL |
| M4 | ACM4 | Human | Acetylcholine (muscarinic) | A | pKi | 5.71 | 5.71 | 5.71 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.64 | 6.64 | 6.64 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.48 | 6.48 | 6.48 | ChEMBL |
| M1 | ACM1 | Human | Acetylcholine (muscarinic) | A | pKi | 5.63 | 5.63 | 5.63 | ChEMBL |
| δ | OPRD | Human | Opioid | A | pKi | 5.06 | 5.06 | 5.06 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.26 | 6.26 | 6.26 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 6.3 | 6.76 | 6.99 | ChEMBL |
| 5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 5.61 | 5.61 | 5.61 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 5.98 | 5.98 | 5.98 | ChEMBL |
| NOP | OPRX | Human | Opioid | A | pKi | 8.09 | 8.09 | 8.09 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| FPR3 | FPR3 | Human | Formylpeptide | A | pIC50 | 5.46 | 5.46 | 5.46 | ChEMBL |
| GPR183 | GP183 | Human | Orphan | A | pIC50 | 5.73 | 5.73 | 5.73 | ChEMBL |
| ADGRF1 | AGRF1 | Human | ADGRF | B2 | pIC50 | 5.55 | 5.55 | 5.55 | ChEMBL |
| CX3CR1 | CX3C1 | Human | Chemokine | A | pIC50 | 5.58 | 5.58 | 5.58 | ChEMBL |
| GPR35 | GPR35 | Human | Orphan | A | pIC50 | 5.35 | 5.35 | 5.35 | ChEMBL |
| FPR1 | FPR1 | Human | Formylpeptide | A | pIC50 | 5.51 | 5.51 | 5.51 | ChEMBL |
| AT1 | AGTR1 | Human | Angiotensin | A | pIC50 | 5.36 | 5.36 | 5.36 | ChEMBL |
| FFA4 | FFAR4 | Human | Free fatty acid | A | pIC50 | 4.99 | 4.99 | 4.99 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 5.41 | 5.41 | 5.41 | ChEMBL |
| S1P1 | S1PR1 | Human | Lysophospholipid (S1P) | A | pIC50 | 5.5 | 5.5 | 5.5 | ChEMBL |
| M2 | ACM2 | Human | Acetylcholine (muscarinic) | A | pIC50 | 5.4 | 5.4 | 5.4 | ChEMBL |
| apelin | APJ | Human | Apelin | A | pIC50 | 5.47 | 5.47 | 5.47 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pIC50 | 5.82 | 5.82 | 5.82 | ChEMBL |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pIC50 | 5.41 | 5.41 | 5.41 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pIC50 | 5.12 | 5.12 | 5.12 | ChEMBL |
| NOP | OPRX | Human | Opioid | A | pIC50 | 7.52 | 7.52 | 7.52 | ChEMBL |
| GPR119 | GP119 | Human | GPR18, GPR55 and GPR119 | A | pIC50 | 5.4 | 5.4 | 5.4 | ChEMBL |